Hochman David P
Company insiders · See Remarks · Director · Orchestra BioMed Holdings, Inc.
- Reported transaction lines
- 1
- Buy lines
- 1
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-111
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Hochman David P See Remarks · Director · Orchestra BioMed Holdings, Inc. | OBIO Orchestra BioMed Holdings, Inc. | BuyFiling detailsSEC transaction code P Common Stock · Indirect ownership · By the DPH 2008 Trust · Reported balance after transaction: 437916 · SEC code covers open-market or private transactions · These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share. · Chief Executive Officer and Chairperson | 2026-11-09 | 2026-11-09 | ≈ $25,000.00 5,000 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.